Showing results (581-590 of 1,278) with videos related to
Sort By:
Pageof 128
Critical Care Medicine|May 19, 2015
Effects of Sigh on Regional Lung Strain and Ventilation Heterogeneity in Acute Respiratory Failure Patients Undergoing Assisted Mechanical VentilationTommaso Mauri, Nilde Eronia, Chiara Abbruzzese, et al.Investigational New Drugs|May 4, 2004
Phase I trial of combined irinotecan and oxaliplatin given every three weeks to patients with metastatic colorectal cancerPaulo M Hoff, Everardo D Saad, Richard Pazdur, et al.Anticancer Research|March 1, 1997
Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancerJ L Abbruzzese, D B Evans, I Raijman, et al.Investigational New Drugs|January 1, 1996
Phase II trial of ZD1694 (Tomudex) in patients with advanced pancreatic cancerR Pazdur, N J Meropol, E S Casper, et al.Journal of the Royal College of Surgeons of Edinburgh|October 1, 1995
Rapid-fractionation pre-operative chemoradiation for malignant periampullary neoplasmsO B Evans, J L Abbruzzese, K R Cleary, et al.Journal of Hematology & Oncology|April 6, 2012
Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progressionDavid Z Chang, Ying Ma, Baoan Ji, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2006
Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancerDonghui Li, Marsha Frazier, Douglas B Evans, et al.Gene Therapy|March 16, 2002
Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trialT Reid, E Galanis, J Abbruzzese, et al.Materials Science & Engineering. C, Materials for Biological Applications|December 1, 2020
Graphene-laden hydrogels: A strategy for thermally triggered drug deliveryEmanuele Mauri, Aurora Salvati, Antonino Cataldo, et al.Journal of Cancer Research and Clinical Oncology|May 28, 2008
A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinomaKimberly B Higginbotham, Richard Lozano, Thomas Brown, et al.Pageof 128